I am the co-founder and chief technology officer at Talus Bio. With over a decade’s experience in analytical chemistry and computational biology, I develop technologies for quantitative proteomics. In particular, at Talus, I’m working on the challenges associated with scaling-up quantitative proteomics experiments. I am directly involved in a large variety of research projects spanning cancer drug discovery, molecular mechanisms of aging, epigenetics, and spatiotemporal proteomics. In addition to my research and leadership roles, I am an active member of several professional organizations, including the American Society for Mass Spectrometry (ASMS), the Human Proteome Organization (HUPO), and US HUPO. I am passionate about community building and mentorship, serving as an organizer for numerous workshops for proteomics, professional skills, and entrepreneurship.

When I’m not working, I enjoy bringing my son to the zoo, reading on my Kindle with a cup of coffee, and running 5ks around Seattle’s parks.

Where in the World is Lindsay?

  • Co-chairing the CompMS “COSI” at the Intelligent Systems for Molecular Biology conference

  • 🤓Attending Bioorganic Chemistry Gordon Research Conference

  • 👥Chemoproteomics workshop panel moderation at ASMS

  • 🎤Selected oral presentation at ASMS, “Integrative regulome profiling of DNA damage responses to discover DNA repair-directed therapeutics in aging”

  • 👥Entrepreneurship workshop panel moderation at ASMS

  • 🎤Invited Sciex breakfast seminar at ASMS, “Chromatogram-based chemoproteomics with the ZenoTOF 8600 system and Skyline”

  • 🎤Invited seminar for Stanford Proteomics Users Group (PUG)

  • 🧑‍🏫Teaching at the “May Institute on Computation and Statistics for Mass Spectrometry and Proteomics” in Boston

  • 🎤Speaking at the AI session of the Life Science Innovation NorthWest conference

  • 👥Biotech Panel, hosted by University of Washington student organizations Project Medicine x FosterMed